Total Payments
$976.13
2024 Payments
$13.48
Companies
6
Transactions
23
Payment Breakdown by Category
Consulting$550.00 (56.3%)
Food & Beverage$426.13 (43.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $550.00 | 1 | 56.3% |
| Food and Beverage | $426.13 | 22 | 43.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neos Therapeutics, LP | $729.30 | 6 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $75.70 | 5 | $0 (2023) |
| Tris Pharma Inc | $69.24 | 5 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $47.93 | 3 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.01 | 2 | $0 (2022) |
| Shire North American Group Inc | $21.95 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.48 | 1 | Tris Pharma Inc ($13.48) |
| 2023 | $12.74 | 1 | Supernus Pharmaceuticals, Inc. ($12.74) |
| 2022 | $111.41 | 7 | Supernus Pharmaceuticals, Inc. ($44.80) |
| 2021 | $66.35 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($19.35) |
| 2020 | $27.51 | 2 | Ironshore Pharmaceuticals Inc. ($14.11) |
| 2019 | $709.96 | 5 | Neos Therapeutics, LP ($699.15) |
| 2018 | $12.73 | 1 | Tris Pharma Inc ($12.73) |
| 2017 | $21.95 | 2 | Shire North American Group Inc ($21.95) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/11/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: ADHD | ||||||
| 10/30/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.74 | General |
| Category: PSYCHOLOGY | ||||||
| 10/25/2022 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: ADHD | ||||||
| 09/19/2022 | Neos Therapeutics, LP | Cotempla XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $16.75 | General |
| Category: ADHD | ||||||
| 07/12/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 03/10/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $15.99 | General |
| Category: PSYCHOLOGY | ||||||
| 02/15/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.05 | General |
| Category: PSYCHOLOGY | ||||||
| 02/09/2022 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $12.76 | General |
| Category: PSYCHOLOGY | ||||||
| 01/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2021 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 08/12/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: PSYCHOLOGY | ||||||
| 03/15/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2021 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: ADHD | ||||||
| 11/16/2020 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ADHD | ||||||
| 03/16/2020 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 11/12/2019 | Tris Pharma Inc | Quillivant XR (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: ADHD | ||||||
| 09/17/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: ADHD | ||||||
| 08/07/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: ADHD | ||||||
| 08/07/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $120.68 | General |
| Category: ADHD | ||||||
| 04/30/2019 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug), Cotempla XR-ODT | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: ADHD | ||||||
| 10/23/2018 | Tris Pharma Inc | Quillivant XR (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: ADHD | ||||||
| 11/06/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $10.44 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Daniel Moran, MD
Dr. Daniel Moran, MD is a Surgery healthcare provider based in Apex, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407860224.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Moran, MD has received a total of $976.13 in payments from pharmaceutical and medical device companies, with $13.48 received in 2024. These payments were reported across 23 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($550.00).
Ad
Practice Information
- Specialty Surgery
- Other Specialties Developmental - Behavioral Pediatrics
- Location Apex, NC
- Active Since 07/28/2006
- Last Updated 06/10/2021
- Taxonomy Code 208600000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407860224
Products in Payments
- Adzenys XR-ODT (Drug) $712.55
- QELBREE (Drug) $75.70
- JORNAY PM (Drug) $47.93
- Dyanavel XR (Drug) $45.70
- VYVANSE (Drug) $42.45
- Quillivant XR (Drug) $23.54
- Cotempla XR-ODT (Drug) $16.75
- MYDAYIS (Drug) $11.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.